Newest Issue is Out. Get your exclusive copy today.
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Eli Lilly and Company in combination with Boehringer Ingelheim has developed Jardiance®, a novel therapy to treat patients with heart failure with preserved ejection fraction (HFpEF). Jardiance is used to lower the blood sugar levels along with diet and exercise in adults with type 2 diabetes, lessens the risk of cardiovascular...
Hutchmed Limited discovered novel therapy amdizalisib (HMPL-689), for the treatment of relapsed or refractory follicular lymphoma (“FL”). Amdizalisib is an inhibitor for PI3Kδ (phosphoinositide 3-kinase delta),a lipid kinase which helps in controlling the activation of several important signaling proteins...
Evren Technologies developed Phoenix®, a novel therapy for the treatment of Post-traumatic Stress Disorder (PTSD). The Phoenix® is an earbud device which delivers a light electrical tingle to activate vagus nerve consisting of a calming effect on the body and also helps in reducing the symptoms of PTSD....
Genentech developed Venclexta in combination with Azacitidine for the treatment of patients with Myelodysplastic Syndromes. Venclexta in combination with Azacitidine has the ability to treat adult patients who have formerly untreated with intermediate, high- and very high-risk myelodysplastic...
Nasopharyngeal Carcinoma in combination with Coherus discovered Toripalimab, novel therapy for the treatment of recurrent or metastatic nasopharyngeal carcinoma. Toripalimab, is an anti-PD-1 monoclonal antibodyhaving the ability to block PD-1interactions with its ligands, PD-L1 and PD-L2, and for enhanced receptor internalization (endocytosis function)....
Mirati Therapeutics discovered novel therapy, Adagrasib for the treatment of patients with non-small cell lung cancer (NSCLC) harbouring the KRASG12C Mutation. Adagrasib is an investigational, selective and oral small-molecule inhibitor of KRASG12C which is developed to support target inhibition, as KRASG12C protein regenerates...
vTv Therapeutics discovered TTP399 therapy for the treatment of patients with Type 1 diabetes. TTP399 is a novel, oral, investigational once-daily glucokinase activator. It is considered to be an adjunctive therapy to insulin for the treatment...
Rusfertide, a breakthrough therapy discovered for the treatment of patients with Polycythemia Vera (PV). Rusfertide reduces the erythrocytosis in those patients who do not require further treatment for thrombocytosis and/or leucocytosis...
BXCL501, a novel therapy developed for the acute treatment of agitation related with dementia. BXCL501 is an investigational orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation in patients with bipolar disorders...
Janssen discovered novel therapy, Teclistamab for the treatment of relapsed or refractory multiple myeloma. Teclistamab is an off-the-shelf, T-cell redirecting, bispecific antibody which targets both B-Cell Maturation Antigen (BCMA) and CD3 receptors...
